Delivery Order SPE2DB22D1106-SPE2DB24FFET3
Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,318.36 firm fixed-price contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a medication primarily used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a completion date of November 26, 2024. This contract is part of...
- This is a $12,433.40 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 230-21 mcg inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a $4,458.80 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,990.96, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 4, 2025. This delivery order is part of a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,807.51 firm fixed-price contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a common pharmaceutical used to treat respiratory conditions. The order has a completion date of February 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,618.85 contract is for the delivery of Advair HFA 230-21 MCG Inhaler, which is a prescription medication. The delivery order is a firm-fixed-price contract with a completion date of September 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,655.25 firm fixed-price contract is for the supply of Advair HFA 230-21 MCG Inhaler, a respiratory medication. The contract has a completion date of June 14, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.66, is for the procurement of an Advair HFA 230-21 MCG Inhaler (12 GM). This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Advair HFA 230-21 mcg inhalers, a prescription medication used to treat asthma and chronic obstructive pulmonary disease. The award has a ceiling value of $16,157.90 and an ultimate completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- This is a $8,600.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 230-21 mcg inhalers, a medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The 12-gram inhalers are scheduled for delivery by June 10, 2025. This award is not a set-aside contract, indicating open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FFET3Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,990.48 firm fixed price contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication used to treat asthma and COPD. This delivery order is against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by July 31, 2024.
Generated 10/29/24, 9:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/30/24 |